We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Tabletop Ultracentrifuge Suitable for Biosafety Hood Use

By LabMedica International staff writers
Posted on 25 Jun 2012
Biotech and other life science research laboratories now have available a new tabletop ultracentrifuge that provides the separation capabilities of free standing centrifuges while being compact enough to fit within a standard biosafety hood.

Beckman Coulter Life Sciences (Brea, CA, USA) recently introduced the Optima MAX-TL tabletop ultracentrifuge. More...
This instrument is fully compatible with Beckman Coulter’s TL labware and fixed-angle, swinging bucket, and unique near-vertical tube (NVT) rotors. Operators have the option of inputting multiple programs of up to five steps each using an easily navigated, full-color LCD touch-screen accessible in nine languages: English, Spanish, German, Japanese, French, Italian, Russian, Portuguese and Chinese (simplified). Context-sensitive onscreen help is available in multiple native languages.

The Optima MAX-TL is capable of reaching a maximum speed of 120,000 rpm and maximum rcf [relative centrifugal force] of 657,000 x g. Temperatures in the centrifuge can be set from 0 to 40 degrees Celsius in one degree Celsius increments. The instrument operates in ambient temperatures from 15 to 35 degrees Celsius.

With its compact size allowing the instrument to be used inside biosafety or laminar flow hoods, the Optima MAX-TL should prove to be an excellent tool for applications such as separation of subcellular particles, separation of viruses and viral particles, rate-zonal separation of proteins in sucrose gradient, separation of lipoproteins, pelleting of RNA through a cesium chloride gradient, isopycnic separation of plasmid DNA, and others.

“The Optima MAX-TL tabletop is an instrument for those working with smaller sample sizes and fills out our best-in-class line of ultracentrifuges,” said Patrick O’Donnell, senior global manager of marketing at Beckman Coulter. “The unit’s features and user-friendly qualities will make it of great service to researchers.”

Related Links:
Beckman Coulter Life Sciences



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.